StrokeNCT05694403
Follow up of Stroke Patients by Neurologists and General Practitioners
An observational study of Stroke, run by Vrije Universiteit Brussel.
Trial summary
From the region around Brussels there are currently few data on how the post-stroke process take place and how satisfied the care providers are with it. For this reason, this survey is set up with the aim of examining four pillars: the epidemiology of stroke, communication between neurologists and GPs and satisfaction… Read more about this study
- Who is it for?
- Ages 24 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Stroke
- What is being tested?
- Survey
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 1 Sep 2023to 30 Jun 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 24 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Neurologists and general practitioners around Brussels
Who may be able to join
- Neurologist and/or general practitioner
Who cannot join
- Not actively treating stroke patients
About this study
Official title: Follow up of Stroke Patients by Neurologists and GP's: How Smooth is the Internal Communication and is There Room for Improvement?
From the region around Brussels there are currently few data on how the post-stroke process take place and how satisfied the care providers are with it. For this reason, this survey is set up with the aim of examining four pillars: the epidemiology of stroke, communication between neurologists and GPs and satisfaction with it, secondary prevention of cardiovascular disease and control/treatment of the most common sequelae after stroke. In the latter two, the emphasis is on detection and treatment, and explicitly on whose task this is (neurologist versus GP), with the aim of verifying the mutual consensus on treatment and the subsequent detection of treatment shortcomings. This study will mainly consist of interviewing general practitioners and neurologists in the periphery of Brussels. This will be done by means of partly structured questionnaires, that will be send out to the medical professionals by contact with the central umbrella organisations of neurology in the hospitals and contact with the various general practitioners' practices (directly or through the multidisciplinary meetings per region). The questionnaires will be made up in google forms, as this programme allows efficient data processing, is eas-ily understandable for every participant and as no individual patient data will be processed.
- Conditions
- Stroke
- Being tested
- Survey
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
Questionnaire
| Study group | Role | What they receive |
|---|---|---|
| Neurologists | Not described Receives: Other: Survey | |
| General practitioners | Not described Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
secondary prevention stroke: Antithrombotics
Given that the purpose of our study is not to determine which antithrombotics are started, this will not be determined. What will be asked, however, is which healthcare provider starts this and whose task this is considered to be. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
secondary prevention stroke: Hypertension
This study will ask who starts antihypertensive drugs, whose task this is considered, how blood pressure is monitored and what the target values are. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
secondary prevention stroke: Smoking
The questionnaire will ask whether healthcare providers themselves actively detect smoking behaviour and how this smoking behaviour is addressed. (ex. via medication, consultation with tabacologist etc) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
secondary prevention stroke: Diabetes
The questionnaire will ask whether diabetes is actively detected by the healthcare provider himself, whether the treatment is subsequently started/adjusted himself and whose task this is according to them (neurologist, GP, diabetologist,...)
At the end, it will also be asked whether healthcare providers would like to see changes in secondary prevention of stroke (open question, all answers will be checked) and whether the healthcare provider considers themselves to be capable enough to follow up secondary prevention in stroke patients (as this seems to be a good measure of the quality of currently available guidelines). Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
secondary prevention stroke: general
At the end, it will also be asked whether healthcare providers would like to see changes in secondary prevention of stroke (open question, all answers will be checked) and whether the healthcare provider considers themselves to be capable enough to follow up secondary prevention in stroke patients (as this seems to be a good measure of the quality of currently available guidelines). Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
sequelae of stroke: Fatigue
During the study, it will check whether fatigue is detected (example: if the treating physician often actively asks the patiënt for mental and/or physical fatigue) and what treatment is instituted. (example: psychologist, physiotherapy,...) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
sequelae of stroke: Depression
The questionnaire will explore whether depression itself is detected by the healthcare provider, how this is done (screening questions, heteroanamnesis,...), whose job it is and whether a referral is made and to whom. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
sequelae of stroke: Sexual dyfunction
This study will evaluate whether sexual dysfunction is being asked, whether and what treatment is initiated. (example: medication, couples therapy etc.) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Measured: 1,5 - 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2023
- Study start1 Sep 2023 (estimated)
- Primary completion1 Jun 2024 (estimated)
- Study completion30 Jun 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by Vrije Universiteit BrusselThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Vrije Universiteit Brussel
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Margaux Vanderstraeten, Vrije Universiteit Brussel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05694403
- Sponsor's protocol ID
- 22258PSFU
- Status last verified
- Aug 2023
- First submitted
- 25 Jul 2022
- Last updated
- 14 Aug 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Follow up of Stroke Patients by Neurologists and GP's: How Smooth is the Internal Communication and is There Room for Improvement?
- ClinicalTrials.gov ID
- NCT05694403
- Acronym / sponsor ID
- 22258PSFU
- Conditions
- Stroke
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Vrije Universiteit BrusselUniversity, hospital or other
- Study start
- 1 Sep 2023 (estimated)
- Primary completion
- 1 Jun 2024 (estimated)
- Study completion
- 30 Jun 2024 (estimated)
- First posted
- 23 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
From the region around Brussels there are currently few data on how the post-stroke process take place and how satisfied the care providers are with it. For this reason, this survey is set up with the aim of examining four pillars: the epidemiology of stroke, communication between neurologists and GPs and satisfaction with it, secondary prevention of cardiovascular disease and control/treatment of the most common sequelae after stroke. In the latter two, the emphasis is on detection and treatment, and explicitly on whose task this is (neurologist versus GP), with the aim of verifying the mutual consensus on treatment and the subsequent detection of treatment shortcomings. This study will mainly consist of interviewing general practitioners and neurologists in the periphery of Brussels. This will be done by means of partly structured questionnaires, that will be send out to the medical professionals by contact with the central umbrella organisations of neurology in the hospitals and contact with the various general practitioners' practices (directly or through the multidisciplinary meetings per region). The questionnaires will be made up in google forms, as this programme allows efficient data processing, is eas-ily understandable for every participant and as no individual patient data will be processed.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Neurologists | – | Other: Survey |
| General practitioners | – | Other: Survey |
Who may qualify
- Ages
- 24 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Neurologists and general practitioners around Brussels
Key inclusion criteria (1 listed)
- Neurologist and/or general practitioner
Key exclusion criteria (1 listed)
- Not actively treating stroke patients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyQuestionnaire | Other | General practitioners, Neurologists |
Primary outcome
secondary prevention stroke: Antithrombotics
Time frame: 1,5 - 2 years
Given that the purpose of our study is not to determine which antithrombotics are started, this will not be determined. What will be asked, however, is which healthcare provider starts this and whose task this is considered to be. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
secondary prevention stroke: Hypertension
Time frame: 1,5 - 2 years
This study will ask who starts antihypertensive drugs, whose task this is considered, how blood pressure is monitored and what the target values are. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
secondary prevention stroke: Smoking
Time frame: 1,5 - 2 years
The questionnaire will ask whether healthcare providers themselves actively detect smoking behaviour and how this smoking behaviour is addressed. (ex. via medication, consultation with tabacologist etc) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
secondary prevention stroke: Diabetes
Time frame: 1,5 - 2 years
The questionnaire will ask whether diabetes is actively detected by the healthcare provider himself, whether the treatment is subsequently started/adjusted himself and whose task this is according to them (neurologist, GP, diabetologist,...) At the end, it will also be asked whether healthcare providers would like to see changes in secondary prevention of stroke (open question, all answers will be checked) and whether the healthcare provider considers themselves to be capable enough to follow up secondary prevention in stroke patients (as this seems to be a good measure of the quality of currently available guidelines). Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
secondary prevention stroke: general
Time frame: 1,5 - 2 years
At the end, it will also be asked whether healthcare providers would like to see changes in secondary prevention of stroke (open question, all answers will be checked) and whether the healthcare provider considers themselves to be capable enough to follow up secondary prevention in stroke patients (as this seems to be a good measure of the quality of currently available guidelines). Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
sequelae of stroke: Fatigue
Time frame: 1,5 - 2 years
During the study, it will check whether fatigue is detected (example: if the treating physician often actively asks the patiënt for mental and/or physical fatigue) and what treatment is instituted. (example: psychologist, physiotherapy,...) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
sequelae of stroke: Depression
Time frame: 1,5 - 2 years
The questionnaire will explore whether depression itself is detected by the healthcare provider, how this is done (screening questions, heteroanamnesis,...), whose job it is and whether a referral is made and to whom. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
sequelae of stroke: Sexual dyfunction
Time frame: 1,5 - 2 years
This study will evaluate whether sexual dysfunction is being asked, whether and what treatment is initiated. (example: medication, couples therapy etc.) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Aug 2023.
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Stroke, run by Vrije Universiteit Brussel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
secondary prevention stroke: Antithrombotics (time frame: 1,5 - 2 years). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2023.